Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma

The resistance of highly aggressive glioblastoma multiforme (GBM) to chemotherapy is a major clinical problem resulting in a poor prognosis. GBM contains a rare population of self-renewing cancer stem cells (CSCs) that proliferate, spurring the growth of new tumors, and evade chemotherapy. In cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Noh, Kum Hee, Lee, Song-Hee, Lee, Haeri, Jeong, Ae Jin, Kim, Kyu Oh, Shin, Hyun Mu, Kim, Hang-Rae, Park, Myung-Jin, Park, Jong Bae, Lee, Jiyoung, Ye, Sang-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577150/
https://www.ncbi.nlm.nih.gov/pubmed/34742152
http://dx.doi.org/10.1016/j.tranon.2021.101255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577150/
https://www.ncbi.nlm.nih.gov/pubmed/34742152
http://dx.doi.org/10.1016/j.tranon.2021.101255

Ejemplares similares